Mycobacterium tuberculosis type VII secretion system effectors differentially impact the ESCRT endomembrane damage response by Mittal, Ekansh et al.
Washington University School of Medicine
Digital Commons@Becker
Open Access Publications
2018
Mycobacterium tuberculosis type VII secretion
system effectors differentially impact the ESCRT
endomembrane damage response
Ekansh Mittal
Washington University School of Medicine in St. Louis
Michael L. Skowyra
Washington University School of Medicine in St. Louis
Grace Uwase
Washington University School of Medicine in St. Louis
Emir Tinaztepe
New York University School of Medicine
Alka Mehra
New York University School of Medicine
See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Mittal, Ekansh; Skowyra, Michael L.; Uwase, Grace; Tinaztepe, Emir; Mehra, Alka; Köster, Stefan; Hanson, Phyllis I.; and Philips,
Jennifer A., ,"Mycobacterium tuberculosis type VII secretion system effectors differentially impact the ESCRT endomembrane
damage response." mBio.9,. e01765-18. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7407
Authors
Ekansh Mittal, Michael L. Skowyra, Grace Uwase, Emir Tinaztepe, Alka Mehra, Stefan Köster, Phyllis I.
Hanson, and Jennifer A. Philips
This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/7407
Mycobacterium tuberculosis Type VII Secretion System
Effectors Differentially Impact the ESCRT Endomembrane
Damage Response
Ekansh Mittal,a,b Michael L. Skowyra,c Grace Uwase,a,b Emir Tinaztepe,d Alka Mehra,d Stefan Köster,d* Phyllis I. Hanson,c
Jennifer A. Philipsa,b,d
aDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis,
Missouri, USA
bDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
cDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri,
USA
dDivision of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York,
New York, USA
ABSTRACT Intracellular pathogens have varied strategies to breach the endolyso-
somal barrier so that they can deliver effectors to the host cytosol, access nutrients,
replicate in the cytoplasm, and avoid degradation in the lysosome. In the case of
Mycobacterium tuberculosis, the bacterium perforates the phagosomal membrane
shortly after being taken up by macrophages. Phagosomal damage depends upon
the mycobacterial ESX-1 type VII secretion system (T7SS). Sterile insults, such as silica
crystals or membranolytic peptides, can also disrupt phagosomal and endolysosomal
membranes. Recent work revealed that the host endosomal sorting complex re-
quired for transport (ESCRT) machinery rapidly responds to sterile endolysosomal
damage and promotes membrane repair. We hypothesized that ESCRTs might also
respond to pathogen-induced phagosomal damage and that M. tuberculosis could
impair this host response. Indeed, we found that ESCRT-III proteins were recruited to
M. tuberculosis phagosomes in an ESX-1-dependent manner. We previously demon-
strated that the mycobacterial effectors EsxG/TB9.8 and EsxH/TB10.4, both secreted
by the ESX-3 T7SS, can inhibit ESCRT-dependent trafﬁcking of receptors to the lyso-
some. Here, we additionally show that ESCRT-III recruitment to sites of endolyso-
somal damage is antagonized by EsxG and EsxH, both within the context of M. tu-
berculosis infection and sterile injury. Moreover, EsxG and EsxH themselves respond
within minutes to membrane damage in a manner that is independent of calcium
and ESCRT-III recruitment. Thus, our study reveals that T7SS effectors and ESCRT par-
ticipate in a series of measures and countermeasures for control of phagosome in-
tegrity.
IMPORTANCE Mycobacterium tuberculosis causes tuberculosis, which kills more peo-
ple than any other infection. M. tuberculosis grows in macrophages, cells that spe-
cialize in engulﬁng and degrading microorganisms. Like many intracellular patho-
gens, in order to cause disease, M. tuberculosis damages the membrane-bound
compartment (phagosome) in which it is enclosed after macrophage uptake. Recent
work showed that when chemicals damage this type of intracellular compartment,
cells rapidly detect and repair the damage, using machinery called the endosomal
sorting complex required for transport (ESCRT). Therefore, we hypothesized that
ESCRT might also respond to pathogen-induced damage. At the same time, our pre-
vious work showed that the EsxG-EsxH heterodimer of M. tuberculosis can inhibit ES-
CRT, raising the possibility that M. tuberculosis impairs this host response. Here, we
show that ESCRT is recruited to damaged M. tuberculosis phagosomes and that
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EsxG-EsxH undermines ESCRT-mediated endomembrane repair. Thus, our studies
demonstrate a battle between host and pathogen over endomembrane integrity.
KEYWORDS ESCRT, endomembrane damage, Mycobacterium tuberculosis, type VII
secretion system, phagosomes
Uptake and lysosomal degradation of microorganisms are a central feature of innateimmunity. In response, pathogens have diverse strategies to prevent their destruc-
tion in the host endolysosomal system. Viruses and certain bacterial pathogens, such as
Listeria and Shigella, escape from the endolysosomal system and replicate in the
cytosol. Bacteria that replicate in a membranous vacuole, such as Legionella and
Salmonella, also have to gain access to the host cytosol. They rely upon specialized
secretion systems to release factors that breach the phagosomal membrane and deliver
effectors to the host cytoplasm that reroute cellular trafﬁcking to generate a replicative
compartment for the bacilli. In the case of Mycobacterium tuberculosis, the ESX-1 type
VII secretion system (T7SS) is essential for bacterial access to the host cytosol (1–4). Host
mechanisms that sense and potentially repair microorganism-induced endolysosomal
damage are not well understood.
Recent work demonstrated that the endosomal sorting complex required for trans-
port (ESCRT) machinery is rapidly recruited to acutely injured endolysosomes (5), raising
the possibility that ESCRTs might also respond to pathogen-induced damage. ESCRT
machinery promotes budding and ﬁssion of membranes in diverse contexts, including
the formation of multivesicular endosomes, cytokinetic abscission, plasma membrane
repair, and viral budding (6, 7). ESCRTs consist of four complexes: ESCRT-0, -I, -II, and -III.
Upstream ESCRT complexes and a variety of adaptors direct the assembly of ESCRT-III
at sites of action, where it performs a membrane-remodeling function. CHMP1 to -7 and
IST1, which are monomeric in the cytoplasm, form polymeric ESCRT-III ﬁlaments that
drive membrane budding or scission. Our ﬁnding that ESCRT-III promotes repair of
small perforations in the endolysosomal membrane (5) led us to investigate whether
macrophages employ ESCRT machinery in the context of pathogen-induced damage
and whether M. tuberculosis manipulates this host response.
We reasoned that the response of the ESCRT system to M. tuberculosis would
depend upon the mycobacterial ESX-1 T7SS. Numerous studies have demonstrated that
both M. tuberculosis and Mycobacterium marinum ΔesxA mutants, which lack the ESX-1
secreted effector EsxA/ESAT-6, do not perforate the phagosome, and they have less
membrane lytic activity than wild-type (WT) mycobacteria (2–4, 8–12). Because the
ESX-1 secretion system as a whole is inactive in ΔesxA mutants, the mechanism of
phagosomal damage has not been clearly deﬁned but likely requires at least one
additional factor that is cosecreted with EsxA by the ESX-1 T7SS (10, 12–17). Recent
work shows that the mycobacterial lipid phthicerol dimycocerosate (PDIM) also works
in concert with the ESX-1-dependent activity to mediate phagosomal damage (18–20).
Damage to the M. tuberculosis phagosome is central to the pathogens’ success, and
ΔesxA and PDIM mutants do not grow well in macrophages or cause disease in mice
(21–24). Presumably the ability of M. tuberculosis to perforate the phagosome is critical
to virulence because that is how M. tuberculosis delivers effectors to the cytosol (25).
Phagosomal damage may also provide the bacilli access to important nutrients. ESX-
1-dependent membrane damage happens early after bacterial uptake, as host sensors
present in the cytosol detect bacterial products and respond within the ﬁrst hours of
infection (8, 26–32). During the course of infection, there is increased phagosomal
damage, and some bacilli eventually translocate to the cytosol (2, 4, 8, 33).
Our previous studies demonstrated both the importance of ESCRTs in microbial
control and that the mycobacterial effectors EsxG and EsxH can antagonize ESCRT-
dependent functions. ESCRT restricts the growth of M. tuberculosis in macrophages,
demonstrating that this machinery plays an intrinsic role in immunity (34–36). The M.
tuberculosis-secreted protein EsxH/TB10.4 can inhibit ESCRT-dependent receptor traf-
ﬁcking (35). EsxH is secreted as a heterodimer with EsxG/TB9.8 by the ESX-3 T7SS. ESX-3
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is one of ﬁve T7SSs in M. tuberculosis and was initially shown to play a role in metal
homeostasis for the bacilli (37–40). In addition to esxG and esxH, the ESX-3 locus
contains pe5 and ppe4, members of the proline-glutamic acid (PE) and proline-proline-
glutamic acid (PPE) families, respectively. ΔesxH mutants fail to secrete EsxG, EsxH, and
PE5, whereas the Δpe5-ppe4 mutant still secretes EsxG-EsxH (41). Importantly, by
analyzing both ΔesxH and Δpe5-ppe4 mutants, we were able to separate phenotypes
related to metal homeostasis from those attributable to EsxG-EsxH, because although
they both have the same iron phenotype, the Δpe5-ppe4 mutant still secretes EsxG-
EsxH (41). Thus, comparison of these strains allowed us to show that EsxH plays an
iron-independent role in virulence, as the ΔesxH mutant is remarkably attenuated in
vivo, whereas the Δpe5-ppe4 mutant strain is not (41). EsxG-EsxH from M. tuberculosis,
but not the nonpathogen Mycobacterium smegmatis, targets the ESCRT-0 protein,
hepatocyte growth factor-regulated tyrosine kinase substrate (HGS/HRS) (35). The
EsxG-EsxH heterodimer directly binds HRS, and ectopic expression of EsxG-EsxH inhibits
the ability of ESCRT to trafﬁc receptors to the lysosome (35). In addition, EsxG-EsxH
impairs major histocompatibility complex class II (MHC-II) antigen presentation, which
appears related to its ability to antagonize ESCRT (42). Thus, we hypothesized that
EsxG-EsxH might impair ESCRT’s response to endolysosomal damage.
M. tuberculosis that breaches the phagosomal system activates autophagy, which
sequesters targeted material in a double-membrane LC3-marked compartment that is
delivered to an autophagolysosome for degradation (3, 43, 44). Similarly, damaged
lysosomes are engulfed by autophagosomes so they can be cleared in a process
referred to as lysophagy (45–48). The rapid response of ESCRTs to endolysosomal
damage has distinct features from lysophagy (5). ESCRTs respond to small perturbations
in the membrane, which are permeable to protons and small molecules, whereas larger
membrane disruptions appear to be required to activate lysophagy. ESCRTs respond to
damage more rapidly than factors directly linked to autophagy, and their recruitment
depends upon the ESCRT-nucleating factors TSG101 and ALIX but not upon the
autophagy protein ATG16L1 (5). While autophagy has been extensively studied in the
context of M. tuberculosis and other intracellular pathogens (49–51), whether there is
also an early and independent host response to phagosomal perforation has not been
explored. Here, we show that ESCRT machinery is recruited to M. tuberculosis phago-
somes in an ESX-1-dependent manner, while at the same time EsxG-EsxH antagonizes
this host ESCRT response. These studies reveal the interplay of T7SS effectors and ESCRT
in the host response to endomembrane damage during M. tuberculosis infection.
RESULTS
ESCRT-III is recruited to M. tuberculosis phagosomes in an ESX-1-dependent
manner. ESCRT-III is recruited to endolysosomes after damage with the lysosomotropic
compound LLOME (L-leucyl–L-leucine O-methyl ester) in a variety of cell types, including
phagocytic THP-1 cells (5). We veriﬁed that the ESCRT-III proteins CHMP1A, CHMP1B,
and CHMP4B rapidly respond to LLOME-induced damage in bone marrow-derived
macrophages (BMDMs) (see Fig. S1 in the supplemental material). To determine
whether ESCRT-III is also recruited to perforated M. tuberculosis phagosomes, we
compared CHMP1A localization in wild-type (WT) M. tuberculosis strain H37Rv- and
ΔesxA mutant-infected BMDMs. We used a ΔesxA mutant strain that has been exten-
sively characterized and is defective in damaging the phagosome (32, 52, 53). We
examined cells 3 h postinfection, before WT bacilli exhibit extensive phagosomal
disruption or overt translocation to the cytosol (2, 4, 32). After infection with WT M.
tuberculosis, 85.2% of bacilli were associated with CHMP1A staining, which appeared in
a punctate pattern adjacent to the bacilli (Fig. 1A to C; see Movie S1 in the supple-
mental material). In contrast, only 14.3% of the ΔesxA mutants were colocalized with
CHMP1A (Fig. 1A to C; see Movie S2 in the supplemental material). In addition, in the
cases where ΔesxA mutant bacilli were associated with CHMP1A, the staining was less
extensive compared to that seen with WT (Fig. 1A and B). The difference in the degree
of CHMP1A colocalization was apparent when we quantiﬁed the phagosomal CHMP1A
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FIG 1 ESCRT-III is recruited to M. tuberculosis (Mtb) phagosomes in an esxA-dependent manner. (A, E, and I) Immunoﬂuorescence (IF) images of CHMP1A (A)
and CHMP4B (E and I) in BMDMs that were uninfected (UI) or infected with PKH-labeled H37Rv (WT) or the ΔesxAmutant or GFP-expressing mc26206 or mc26230
(ΔRD1) for 3 h. Images are maximum-intensity projections. Scale bar, 10 m. Boxed areas in the merged image are shown in higher magniﬁcation in the
rightmost panel. (B and F) Three-dimensional renderings of individual bacilli, which are also shown in Movies S1 to S4. (C and G) The percentages of bacteria
in CHMP1A- and CHMP4B-positive phagosomes were quantiﬁed from over 100 bacteria by an individual blind to sample identity (****, P 0.0001 for CHMP1A,
and **, P 0.0079 for CHMP4B, Fisher’s exact test). Automated image analysis was used to quantify the mean ﬂuorescence intensity (MFI) of CHMP1A (D) and
CHMP4B (H and J) colocalized with individual bacilli from 5 ﬁelds from a 12-mm coverslip. Data are means  SEM from one representative experiment of three
for H37Rv strains or two independent experiments for mc26206 and mc26230. *, P 0.05, **, P 0.01, and ***, P 0.001, Student’s t test.
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signal using automated image analysis as previously described (35, 52, 54) (Fig. 1D). As
for CHMP1A, CHMP4B was also more extensively colocalized with WT M. tuberculosis
than the ΔesxA mutant (Fig. 1E to H; see Movies S3 and S4 in the supplemental
material). To verify the role of ESX-1, we compared two candidate vaccine strains of M.
tuberculosis: mc26230, which carries a deletion (ΔRD1) that is similar to the one
disrupting ESX-1 in Mycobacterium bovis BCG, and mc26206, in which ESX-1 is intact. We
found reduced CHMP4B recruitment to the ΔRD1 strain, as we had for the ΔesxAmutant
(Fig. 1I and J). Overall, we conclude that ESCRT-III is recruited to M. tuberculosis
phagosomes in an ESX-1-dependent manner, consistent with its recruitment to sites of
endomembrane damage (5). Interestingly, in addition to recruitment to M. tuberculosis
phagosomes, there was an overall change in the cellular distribution of CHMP1A and
CHMP4B in macrophages infected with M. tuberculosis compared to uninfected cells. In
uninfected macrophages, ESCRT-III proteins appeared diffusely cytosolic;M. tuberculosis
infection resulted in a punctate distribution, similar to that seen in cells treated with
lysosomolytic LLOME (5). This punctate distribution was less pronounced during infec-
tion with the ΔesxA mutant, revealing that M. tuberculosis, in an ESX-1-dependent
manner, causes widespread endomembrane damage or otherwise manipulates ESCRT-
III localization.
EsxG-EsxH inhibits ESCRT-III recruitment to phagosomes. Next we asked
whether EsxG-EsxH inﬂuences ESCRT-III recruitment to phagosomes by comparing the
association of CHMP1A, CHMP1B, and CHMP4B with WT and ΔesxH mutant bacilli. In
contrast to our ﬁndings with the ΔesxA mutant, which showed reduced ESCRT-III
recruitment, we found more robust colocalization of CHMP1A, CHMP1B, and CHMP4B
with the ΔesxH mutants (Fig. 2A to H). ESCRT-III recruitment to the ΔesxH mutant was
reduced toward WT levels when EsxG-EsxH was provided to the ΔesxH mutant on an
integrating plasmid (Fig. 2E and H). Macrophages that are infected with a high
intracellular burden of M. tuberculosis undergo host cell death in a manner that
depends upon lysosomal proteases, suggesting that under conditions of high M.
tuberculosis burden, endolysosomal damage is more extensive (55). Interestingly, the
recruitment of ESCRT-III to a subset of ΔesxH bacilli was particularly prominent in
heavily infected macrophages (see Fig. S2A and B in the supplemental material). The
increase in ESCRT-III recruitment during infection did not reﬂect a change in the amount
of CHMP1A or CHMP1B protein, which was unaffected by infection or the pre-
sence of esxH, even at multiplicities of infection (MOI) up to 50 (Fig. S2C).
To determine whether the enhanced ESCRT recruitment is related to the defect in
iron acquisition by the ΔesxHmutant, we compared the ΔesxHmutant to the Δpe5-ppe4
mutant. The ESX-3 machinery secretes EsxG, EsxH, and PE5 (41). ΔesxH and Δpe5-ppe4
mutants are defective in growing on solid medium, unless the medium is supple-
mented with exogenous iron (41). However, while the ΔesxH mutant fails to secrete
EsxG, EsxH, and PE5, the Δpe5-ppe4mutant still secretes EsxG-EsxH (41). Since secretion
of EsxG-EsxH is absent in the ΔesxH strain and present in the Δpe5-ppe4 mutant, by
analyzing both mutants, we can separate phenotypes related to metal homeostasis,
impaired in both, to phenotypes attributable to EsxG-EsxH, impaired exclusively in the
ΔesxH mutant. When we examined phagosomal recruitment of CHMP1A, CHMP1B, or
CHMP4B to Δpe5-ppe4 phagosomes, there was no difference compared to infection
with WT M. tuberculosis (Fig. 2A to D, F, and G). We conclude that the effect of esxH on
ESCRT-III is not related to its role in iron metabolism. Thus, whereas ESX-1 promotes
ESCRT-III recruitment to M. tuberculosis phagosomes (Fig. 1), EsxG-EsxH impairs recruit-
ment.
EsxG-EsxH alters the phagolysosomal damage response and trafﬁcking. Exten-
sively damaged phagosomes and endosomes can be detected by cytoplasmic galec-
tins, such as GAL3, which recognize disrupted compartments by binding to lumenal
glycans that become exposed to the cytosol (56). In addition, phagosomal damage
triggers protein ubiquitination. Both ubiquitinated proteins and galectins recruit au-
tophagy receptors, such as p62, CALCOCO2/NDP52, and NBR1 to phagosomes dis-
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rupted by mycobacteria (3, 52, 56–58). Accordingly, GAL3 and ubiquitin are both
reduced on phagosomes containing the ΔesxA mutant, which does not efﬁciently
damage the phagosome (3, 32, 52). We next asked whether the ΔesxH mutant colo-
calized more with GAL3 and conjugated ubiquitin, as it did with ESCRT-III. Interestingly,
FIG 2 EsxH antagonizes ESCRT-III recruitment. (A, B, and C) IF images of CHMP1A (A), CHMP1B (B), and CHMP4B (C)
with DsRed-expressing H37Rv or ΔesxH and Δpe5-ppe4 (Δppe) mutants 3 hpi in BMDMs. Images are maximum-
intensity projections. Scale bar, 10 m. Boxed areas in the merged image are shown in higher magniﬁcation in the
rightmost panel. Mtb, M. tuberculosis. (D to H) Automated image analysis was used to quantify the MFI of CHMP1A
(D and E), CHMP1B (F), and CHMP4B (G and H) colocalized with individual bacilli in 5 ﬁelds from a 12-mm coverslip.
In panels E and H, BMDMs were infected with the PKH-labeled ΔesxH or ΔesxH::esxH mutant for 3 h. Data are
means  SEM from one representative experiment from three (for the WT and ΔesxH mutant in panels A to D, F,
and G and the Δpe5-ppe4 mutant in panels A, C, D, and G) or two (for panels E and H and the Δpe5-ppe4 mutant
in panels B and F) independent experiments. *, P 0.05, **, P 0.01, ***, P 0.001, and ****, P 0.0001, Student’s
t test. ns, not signiﬁcant.
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phagosomes containing ΔesxH mutants exhibited increased colocalization with GAL3
compared to phagosomes containing WT bacilli, whereas ubiquitin association was
reduced (Fig. 3A to D). Hence, the ΔesxH mutant appears to provoke an enhanced and
altered response to damage.
To determine whether the altered response to phagosomal damage inﬂuenced
phagosomal maturation, we examined the colocalization of WT, ΔesxH, and Δpe5-ppe4
bacteria with LAMP1, a late endosomal and lysosomal marker. There was markedly
enhanced colocalization between LAMP1 and the ΔesxHmutant compared to WT bacilli
(Fig. 3E and F). The enhanced LAMP1 localization with the ΔesxH mutant was comple-
mented by EsxG-EsxH expressed from an integrated plasmid (see Fig. S3A and B in the
supplemental material). In the case of the Δpe5-ppe4 mutant, there was a statistically
signiﬁcant, but very modest, difference in LAMP1 colocalization based upon automated
quantiﬁcation, which was subtle upon visual inspection (Fig. S3C and D). We conclude
that in addition to impairing recruitment of ESCRTs to mycobacterium-containing
phagosomes, EsxG-EsxH also impedes the conversion of phagosomes into lysosomes,
consistent with our previous studies showing that M. tuberculosis strains engineered to
overexpress EsxG-EsxH are better able to arrest phagosome maturation than WT strains
(35).
FIG 3 EsxG-EsxH alters phagosomal GAL3, ubiquitin, and LAMP1. (A, C, and E) IF images of GAL3 (A), ubiquitin (FK2
antibody) (C), and LAMP1 (E) in BMDMs that were infected with DsRed-expressing H37Rv (WT) or the ΔesxHmutant
for 3 h. Images are maximum-intensity projections. Scale bar, 10 m. Boxed areas in the merged image are shown
in higher magniﬁcation in the rightmost panel. Mtb, M. tuberculosis. (B, D, and F) Automated image analysis was
used to quantify the MFI of GAL3 (B), ubiquitin (D), and LAMP1 (F) colocalized with individual bacilli from 5 ﬁelds
of a 12-mm coverslip. Data are means SEM from one representative experiment from three (A, B, E, and F) or two
(C and D) independent experiments. ****, P 0.0001, Student’s t test.
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EsxG-EsxH impairs ESCRT-III recruitment to damaged endomembranes. Given
the complexity of the host-pathogen interactions during infection, we turned to a
simpliﬁed system to clarify the apparent antagonism between EsxG-EsxH and damage-
triggered ESCRT recruitment. We compared the ESCRT response to LLOME in HeLa cells
transfected with a plasmid encoding EsxG-EsxH to cells transfected with a control
vector. LLOME treatment for 15 min caused robust formation of ALIX, CHMP1B,
CHMP4A, and IST1 punctae, as previously reported (see Fig. S4 in the supplemental
material) (5). Interestingly, cells transfected with EsxG-EsxH had fewer CHMP1B and
CHMP4A punctae than vector control cells (Fig. 4A to D). The reduction in CHMP1B and
CHMP4A punctae was not caused by less ESCRT-III protein, as EsxG-EsxH did not impact
their protein levels based upon Western blotting (see Fig. S5 in the supplemental
material). We considered the possibility that M. tuberculosis EsxG-EsxH might reduce
LLOME-induced damage, rather than impairing the ESCRT-III response to such damage.
To assess the degree of membrane damage induced by LLOME, we preloaded the
endolysosomal system with sulforhodamine B (SRB), a 559-Da ﬂuorescent, membrane-
impermeable molecule. Using live-cell imaging, we observed that the majority of SRB
punctae were gone within 30 min of LLOME treatment, reﬂecting a loss of endomem-
brane integrity (Fig. 4E). In cells transiently transfected with EsxG-EsxH, we assessed the
loss of SRB ﬂuorescence and appearance of CHMP4A punctae on an individual cell
basis. We found that expression of M. tuberculosis EsxG-EsxH was negatively correlated
with the number of CHMP4A punctae; however, there was no correlation between
EsxG-EsxH expression and loss of SRB signal (Fig. 4E to G). When we compared those
cells with in which the EsxG-EsxH MFI exceeded an empirical threshold to those with a
lower mean ﬂuorescent intensity (MFI), cells with the brighter EsxG-EsxH signal had
fewer CHMP4A punctae, but there was no difference in the response of SRB (Fig. 4E to
G). This demonstrates that EsxG-EsxH did not impair the ability of LLOME to cause
membrane damage, but rather impaired the response to damage. In addition, we
previously showed that M. tuberculosis EsxG-EsxH can inhibit ESCRT-dependent traf-
ﬁcking functions in cells, whereas EsxG-EsxH from the nonpathogenic species M.
smegmatis does not (35). Consistent with that observation, only M. tuberculosis EsxG-
EsxH was negatively correlated with the number of CHMP4A punctae (Fig. 4H). Overall,
we conclude that M. tuberculosis EsxG-EsxH can impair the recruitment of ESCRT-III to
endomembrane damage.
EsxG-EsxH responds to endomembrane damage. To better understand how
EsxG-EsxH can modulate the host endomembrane damage response, we examined the
behavior of these mycobacterial effectors themselves with regard to sterile endomem-
brane disruption. Unexpectedly, we found that EsxG-EsxH accumulated on numerous
discrete punctae in cells treated with LLOME (Fig. 5). These structures colocalized
partially with CHMP1B and CHMP4A (Fig. 5A and B), and they were apparent within
minutes (Fig. 5C), similar to the rapid response previously reported for ESCRT-III (5). Brief
exposure to LLOME has been shown to induce transient ESCRT-III recruitment to
damaged endolysosomes (5). Similarly, we found that when cells were treated with
LLOME for 1 min followed by removal of the compound, structures enriched for
EsxG-EsxH formed quickly after LLOME addition and were largely resolved by 30 min
after washout (Fig. 5D and E). The response of EsxG-EsxH to LLOME-induced damage
was not a property speciﬁc to M. tuberculosis EsxG-EsxH, as the M. smegmatis EsxG-EsxH
proteins exhibited the same behavior (Fig. 5F), whereas a control protein, LacZ, did not
(Fig. 5G). The response of EsxG-EsxH was not speciﬁc to LLOME-induced damage, as
damage induced by silica also resulted in the localization of EsxG-EsxH, along with
CHMP4A, to the particles (Fig. 5H). Although both CHMP4A and EsxG-EsxH localized to
silica, their staining patterns were quite distinct. EsxG-EsxH staining appeared even and
continuous, adjacent to regions that had CHMP4A punctae. These data suggest that
both M. smegmatis and M. tuberculosis EsxG-EsxH respond to sterile membrane dam-
age, recognizing either the damaged membrane itself or recruited proteins.
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Relationship of HRS to EsxG-EsxH and the membrane damage response. We
considered the possibility that EsxG-EsxH might be recruited to damaged endomem-
branes by interacting with ESCRT machinery, since we previously showed that EsxG-
EsxH can bind the ESCRT-0 component HRS (35). In support of the idea that EsxG-EsxH
acts on HRS during infection, macrophages infected with either WT or the Δpe5-ppe4
FIG 4 EsxG-EsxH impairs ESCRT-III recruitment to damaged lysosomes. (A and C) HeLa cells transfected with M.
tuberculosis (Mtb) EsxG-EsxH (GH) or the vector control were treated with LLOME or the solvent control and stained
for CHMP1B (A) or CHMP4A (C). ESCRT-III and EsxG-EsxH are shown in green and red, respectively. EsxG-EsxH was
visualized with an anti-EsxG-EsxH monoclonal antibody. (B and D) Automated image analysis was used to quantify
the number of CHMP1B (A) or CHMP4A (B) punctae on 30 macrophages per sample. Data are means  SEM from
one representative experiment from at least three independent experiments. ***, P 0.001, and ****, P 0.0001,
Student’s t test. (E) HeLa cells were transfected with Mtb EsxG-EsxH and loaded with SRB. Live-cell imaging was
used to visualize SRB before and after addition of LLOME, after which cells were ﬁxed and stained to visualize
EsxG-EsxH (green) and CHMP4A (magenta). Image panels of representative cells are shown at the times indicated
from each recording. Individual cells are outlined by white dashed lines. Images are maximum-intensity projections.
Scale bars, 10 m. (F and G) Automated image analysis was used to quantify the number of CHMP4A punctae, the
reduction in SRB signal, and the MFI of EsxG-EsxH on a per cell basis. The number of CHMP4A punctae and the
reduction is SRB signal were compared in cells with an EsxG-EsxH MFI greater than and less than 500. Data are
means  SEM from one representative experiment from at least three independent experiments. ***, P 0.001,
Student’s t test. ns, not signiﬁcant. (H) HeLa cells transfected with Mtb or M. smegmatis (Msmeg) EsxG-EsxH were
treated with LLOME, and CHMP4A and EsxG-EsxH were visualized. Automated image analysis was used to quantify
the EsxG-EsxH MFI and the number of CHMP4A punctae in individual cells. The correlation between EsxG-EsxH
expression and number of CHMP4A punctae is shown (R value). Data are means  SEM from four independent
experiments in which at least 100 cells were evaluated.
M. tuberculosis, ESCRT, and Endomembrane Damage ®
November/December 2018 Volume 9 Issue 6 e01765-18 mbio.asm.org 9
 o
n
 January 11, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
mutant bacteria exhibited reduced endosomal staining of HRS compared to uninfected
macrophages (59), whereas no effect on HRS distribution was apparent in macrophages
infected with the ΔesxG or ΔesxH mutant (Fig. 6A and B; see Fig. S6A and B in the
supplemental material). There was no impact of infection or EsxG-EsxH on the distri-
bution of another early endosomal protein, early endosomal antigen 1 (EEA1) (Fig. S6C
and D). The decrease in HRS-positive structures seen during infection did not reﬂect a
change in the amount of HRS protein, which was unaffected by infection or the
presence of esxH (Fig. 6C). We also examined HRS localization by immunoelectron
microscopy and conﬁrmed that there was a signiﬁcant difference in the protein’s
FIG 5 EsxG-EsxH relocalizes in response to membrane damage. HeLa cells transfected with M. tuberculosis (Mtb)
EsxG-EsxH were treated with LLOME, and CHMP1B (A) or CHMP4A (B) (red) and EsxG-EsxH (green) was visualized
by IF. (C) HeLa cells expressing Mtb EsxG-EsxH were treated with LLOME or the solvent control for 2.5 min.
EsxG-EsxH is shown in red. (D) HeLa cells expressing Mtb EsxG-EsxH were treated with LLOME for 1.0 min and then
incubated in excess LLOME-free medium for 5 to 30 min as indicated and stained for CHMP4A (green) and
EsxG-EsxH (red). (E) Automated image analysis was used to quantify the number of CHMP4A punctae on 30
macrophages per sample from panel D. Data are means  SEM from one representative experiment from at least
two independent experiments. ***, P 0.001, Student’s t test. (F and G) HeLa cells expressing Ms EsxG-EsxH (green)
(F) or LacZ (vector control [red]) (G) were treated with LLOME or the solvent control. (H) U2OS cells transfected with
Mtb EsxG-EsxH were treated with silica (SiO2) nanoparticles for 15 min and stained for CHMP4A (red) and EsxG-EsxH
(green). White arrows indicate the silica nanoparticles. (A to H) Both EsxG-EsxH and LacZ were detected with anti-V5
antibody. Nuclei were stained with DAPI. Images are maximum-intensity projections. Scale bar 10 m.
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distribution in macrophages infected with WT bacilli versus macrophages infected with
the ΔesxHmutant (Fig. 6D and E). Notably, HRS associated signiﬁcantly more with ΔesxH
phagosomes than those containing WT bacilli. Thus,M. tuberculosis EsxG-EsxH alters the
localization of HRS in infected macrophages and impairs recruitment of the protein to
mycobacterial phagosomes.
During receptor trafﬁcking, HRS serves as an adaptor to recruit downstream ESCRT
complexes to receptors that have been ubiquitinated, thereby routing them for deg-
radation (6). We accordingly asked whether HRS might also function as an adaptor to
recruit ESCRT machinery to disrupted endomembranes. If so, the ability of EsxG-EsxH to
FIG 6 EsxG-EsxH alters HRS localization during infection. (A) BMDMs were uninfected (UI) or infected with H37Rv
(WT), the ΔesxH or ΔesxG mutant, or the ΔesxG complemented strain for 3 h, and HRS was examined by IF. Mtb,
M. tuberculosis. (B) The number of HRS punctae was quantiﬁed. Data are means  SEM from three independent
experiments. ****, P 0.0001, and ***, P 0.0005, one-way ANOVA with Tukey’s multiple-comparison test. ns, not
signiﬁcant. (C) BMDMs were uninfected or infected with the WT or ΔesxH mutant for 1 to 4 h at a multiplicity of
infection (MOI) of 10 to 50 as indicated. HRS and -actin were examined by Western blotting. (D) Immunoelectron
microscopy of BMDMs infected for 3 h with the WT and ΔesxH mutant. Red arrows indicate anti-HRS gold particles
on M. tuberculosis phagosomes, while vesicular and cytosolic gold particles are indicated with orange and black
arrows, respectively. Bacteria are labeled “B.” (E) The subcellular localization of anti-HRS gold particles was
quantiﬁed from two independent experiments by an investigator blind to sample identity. At least 25 images with
at least 174 bacilli per sample were analyzed. The number of anti-HRS gold particles in each sample is indicated
(n). ****, P 0.0001, Fisher’s exact test.
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bind HRS might explain both the localization of EsxG-EsxH to membrane damage, as
well as the ability of EsxG-EsxH to antagonize damage-triggered ESCRT recruitment.
However, when we examined HRS localization in LLOME-treated cells, we found that
the protein remained associated with EEA1-marked early endosomes and did not
localize to damaged endolysosomes that recruited CHMP4A (Fig. 7A and B). In addition,
we previously showed that HRS preferentially binds M. tuberculosis EsxG-EsxH over M.
smegmatis EsxG-EsxH, but here we found that EsxG-EsxH from both species responded
similarly to LLOME-induced damage (Fig. 5C and F), suggesting that HRS is not what is
driving their recruitment. To test whether HRS is required for the ESCRT-III response to
endomembrane damage, we used previously validated small interfering RNAs (siRNAs)
to deplete HRS (35, 42). As a positive control, we depleted cells of TSG101, a component
of ESCRT-I, which we previously showed is required for damage-triggered ESCRT
recruitment (5). Silencing of HRS and TSG101 resulted in the expected accumulation of
ubiquitinated proteins on endosomes (Fig. 7C), consistent with their well-established
role in receptor trafﬁcking. As recently reported, the response of ESCRT-III to LLOME-
FIG 7 HRS is not required for ESCRT-III endomembrane damage response. (A and B) HRS does not assemble with
ESCRT machinery on LLOME-disrupted endolysosomes. U20S cells were treated with LLOME or the solvent control
for 10 min and then stained for HRS and EEA1 (A) or for HRS and CHMP4A (B). Boxed areas are magniﬁed at right.
The middle two columns show each indicated stain in grayscale; overlap of both stains in leftmost and rightmost
columns appears white. Individual cells are outlined by white dashed lines; scale bars equal 10 m (2 m in
magniﬁed views). (C) RAW cells were treated with siRNA to deplete HRS or TSG101 for 2 days. Macrophages were
then treated with LLOME for 15 min, and ubiquitin (FK2 antibody [red]) and CHMP4B (green) were examined.
FK2-positive cells are outlined by white dashed lines. (D and E) Automated image analysis was used to quantify the
mean ﬂuorescent intensity (MFI) of FK2 (D) or the number of CHMP4B (E) punctae on 50 macrophages per sample.
The number of CHMP4B punctae was compared in cells with FK2 MFI greater than and less than 700. Data are
means  SEM from one representative experiment from at least two independent experiments. ****, P 0.0001,
Student’s t test. ns, not signiﬁcant. (F) HeLa cells were transfected with M. tuberculosis (Mtb) EsxG-EsxH or vector
control, preincubated for 1 h with BAPTA-AM, and then treated with LLOME for 15 min and stained for CHMP4A
(green) and EsxG-EsxH (red). EsxG-EsxH was detected with anti-V5 antibody. Nuclei were stained with DAPI. Images
are maximum-intensity projections. Scale bar, 10 m.
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induced damage was impaired in the absence of TSG101 (Fig. 7C) (5). In contrast,
ESCRT-III responded indistinguishably to LLOME-induced damage in control cells and
HRS-depleted cells, even though the HRS-silenced cells were defective in receptor
trafﬁcking (Fig. 7D). To quantify the effect of HRS and TSG101 silencing on the
endomembrane damage response, we compared those cells within which the MFI of
ubiquitinated proteins exceeded 700 (identifying those cells with impaired receptor
trafﬁcking) to those with a lower MFI. In the case of TSG101 silencing, there were fewer
CHMP4B punctae in cells with impaired receptor trafﬁcking (MFI of 700). In contrast,
in those HRS-silenced cells that showed impaired receptor trafﬁcking, there was no
difference in the response of CHMP4B to LLOME (Fig. 7E). Thus, we conclude that HRS
does not contribute signiﬁcantly toward recruiting ESCRTs to disrupted endolysosomes.
Both EsxG-EsxH and ESCRT-III were recruited to LLOME-induced structures with
similar kinetics (Fig. 5D and E), so we considered the possibility that EsxG-EsxH was
recruited by ESCRT proteins other than HRS. To test whether the recruitment of
EsxG-EsxH to sites of LLOME-induced damage depends upon the ESCRT-III response to
such damage, we made use of the cell-permeable calcium chelator BAPTA-AM. As
previously shown, when we pretreated cells with BAPTA-AM, CHMP4A no longer
robustly responded to LLOME-induced damage (5). However, BAPTA-AM treatment had
no impact on the response of EsxG-EsxH to such damage (Fig. 7F). Thus, EsxG-EsxH
localizes to sites of endomembrane damage independently of ESCRT-III. Overall, we
conclude that mycobacterial EsxG-EsxH antagonizes the recruitment of host ESCRT
machinery to endomembrane damage in a manner that is unrelated to its interaction
with HRS. Instead, EsxG-EsxH appears to recognize a feature of endomembrane damage
independently of ESCRTs and therefore might modulate host membrane damage
responses in a currently unappreciated way that includes inhibition of ESCRT recruit-
ment.
DISCUSSION
Specialized membrane-bound organelles are a deﬁning feature of eukaryotic cells. In
the endolysosomal network, foreign material and degradative enzymes are sequestered
away from the cytosol. It was recently shown that the ESCRT machinery plays an
important role in maintaining the integrity of this compartment, responding to and
repairing minor damage caused by chemical and particulate insults. More extensive
damage, including damage inﬂicted by intracellular pathogens, is detected by host
galectins and cleared by autophagy. In the case of M. tuberculosis, phagosomal damage
depends upon the ESX-1 secretion system and has been most deﬁnitively demon-
strated after several days of infection. However, minor membrane perforation must
happen within the ﬁrst hours after infection, because macrophages quickly respond to
bacterial products in the cytosol. Here, we show that ESCRT-III proteins are recruited to
M. tuberculosis phagosomes during these ﬁrst hours of infection. WT bacilli recruit
ESCRT-III much more extensively than mutants lacking esxA, consistent with the idea
that ESCRT-III is responding to endomembrane damage. Although we observed much
less recruitment of ESCRT-III to the esxA mutant than WT bacilli, we did still see some
recruitment, suggesting there is a low level of ESX-1-independent phagosomal damage
as well. Interestingly, after M. tuberculosis infection, the number of ESCRT-III punctae
increased throughout the cell, suggesting that M. tuberculosis damages subcellular
compartments beyond the phagosome. We speculate that the damage is caused by
ESX-1 effector(s) and PDIM trafﬁcking through the endolysosomal system, as has been
shown for a number of other M. tuberculosis surface proteins and lipids (60, 61).
The idea that ESCRT responds to endosomal perturbation from microorganisms ﬁts
well with our previous studies and those of others showing that ESCRT plays an
evolutionarily conserved role controlling intracellular microbes. RNA interference (RNAi)
screens and follow-up studies demonstrated that ESCRT is important in restricting the
growth of a variety of microbes, including rapidly growing mycobacteria such as
Mycobacterium fortuitum and Mycobacterium smegmatis, as well as slow growers,
including M. bovis BCG and M. tuberculosis (34–36). We propose that even though M.
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smegmatis,M. fortuitum, andM. bovis BCG do not have dedicated systems to breach the
phagosomal membrane, they still cause minor perturbations, which without ESCRT-
mediated repair, would compromise compartmental integrity and, in particular, com-
partmental pH. This could explain why ESCRT silencing impairs lysosomal trafﬁcking
and phagosomal acidiﬁcation not only for M. tuberculosis, but also for these nonpatho-
genic mycobacteria. Moreover, consistent with the idea that ESCRT maintains phago-
somal integrity, RNAi screens in Listeria demonstrated that mutants lacking the cyto-
lysin LLO, which normally fail to enter the host cytosol, are able to do so in cells lacking
ESCRT (62). We also found previously that ESCRT silencing impairs antigen processing
and MHC-II antigen presentation (42), and defective endomembrane integrity might
contribute to these ﬁndings. Interestingly, in gamma interferon (IFN-)-activated mac-
rophages, there is no effect of ESCRT silencing on mycobacterial phagolysosomal
trafﬁcking or host control of infection (42). We speculate that because IFN- induces
autophagy (43), which can also resolve endomembrane damage, activated macro-
phages are less dependent upon ESCRT-mediated repair. In addition, IFN- activates a
Rab20-dependent pathway that promotes the formation of spacious vacuoles and
thereby preserves phagosome integrity (63). Activated macrophages may thus mini-
mize their need for ESCRT-promoted repair. Overall, we favor the idea that a major
contribution of ESCRT to control of intracellular bacteria is related to its function in
endomembrane repair, which is important for maintaining endolysosomal competence,
restricting cytosolic access of microbes, and dampening inﬂammatory signaling. We
cannot rule out the possibility that ESCRT is important in phagosome maturation based
upon its role in receptor trafﬁcking, but it is less clear how this would work. In addition,
ESCRT participates in diverse aspects of cell biology, including plasma membrane repair
and exosome formation, which may all be signiﬁcant, depending on the nature of the
infection.
The idea that ESCRT plays an important role in host control of infection is under-
scored by our ﬁndings that M. tuberculosis EsxG-EsxH impairs ESCRT. Our previous
studies showed that EsxG-EsxH plays a critical role in M. tuberculosis virulence: mutants
lacking EsxH are highly attenuated in mice and impaired in macrophages, phenotypes
that are not explained by defective iron uptake and which are not complemented by
the EsxG-EsxH homologues fromM. smegmatis (41). We propose that T7SS effectors and
ESCRT participate in a series of measures and countermeasures that control of phago-
some integrity (Fig. 8). In the case of WT M. tuberculosis, the ESX-1 system, along with
PDIM, damages the phagosomal membrane. At the same time, EsxG-EsxH prevents
recruitment of ESCRT to sites of damage, ensuring sustained phagosomal perforation
and contributing to impaired lysosomal maturation (Fig. 8A). In the case of the ΔesxA
mutant, membrane damage is minimal, and there is correspondingly little ESCRT
recruitment. Since the ΔesxA mutant is unable to efﬁciently deliver effectors to the
cytosol, it is cleared (Fig. 8B). During infection with the ΔesxH mutant, damage occurs,
and in the absence of EsxG-EsxH, ESCRT is more robustly recruited than in WT infections
(Fig. 8C).
Although ESCRT-III is recruited to the ΔesxH mutant, it is not clear to what degree
it can repair pathogen-induced damage in this context. Since we observed discordant
results in the recruitment of GAL3 and ubiquitin—both markers of phagosomal dam-
age—it is difﬁcult to infer the fate of the damaged membrane. Although GAL3 is
recruited to damaged phagosomes by binding endosomal glycoproteins that become
exposed to the cytosol, it has also been reported to interact with ESCRT-tethering
proteins ALIX and TSG101 (64–66), so GAL3 may be recruited or retained independently
of damage. Ubiquitin deposition is also an indirect measure of phagosomal damage,
and, furthermore, is inﬂuenced by endocytic cargo sorting. Moreover, since GAL3 is
reported to inhibit parkin-mediated ubiquitination (67), the two markers may not be
independent. Despite uncertainty about whether ESCRT-III repairs the damage during
infection with the ΔesxH mutant, it is clear that without EsxG-EsxH there is a more
robust ESCRT response at the mycobacterium-containing phagosomal membrane, and
the pathogen no longer successfully orchestrates its virulence program. Given the
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importance of phagosome integrity for the host and pathogen, both in terms of
microbial control and also inﬂammatory responses, it seems likely that other patho-
gens, including viruses, engage ESCRT over its role in membrane repair.
How might EsxG-EsxH antagonize ESCRT? One possibility is that the difference in the
ESCRT response to infection with the ΔesxH mutant is related to intrinsic differences in
the bacteria. For example, EsxG-EsxH might inhibit the membranolytic activity of M.
tuberculosis. In this case, ESCRT would be more robustly recruited to the ΔesxH mutant
because the mutant generates more membrane damage than WT bacilli. However, at
least in vitro, there is no cross-regulation of the ESX-1 and ESX-3 systems in terms of
effector secretion (41, 68). It is possible that after they are secreted from the bacilli,
ESX-1 and ESX-3 effectors have opposing activities at the phagosome. However, we
found that EsxG-EsxH can also impair ESCRT-III recruitment in the context of sterile
damage, suggesting that EsxG-EsxH operates independently of other bacterial factors.
We favor the idea that EsxG-EsxH antagonizes ESCRT by virtue of interacting with either
host membranes or proteins. Although EsxG-EsxH can bind HRS (35) and alter HRS
localization during infection (Fig. 6), our data suggest that HRS is not the relevant ESCRT
FIG 8 Model depicting how the presence of ESCRT at the M. tuberculosis phagosome is determined by
ESX-1 and ESX-3. (A) In WT bacilli, ESX-1 effectors generate phagosomal damage. EsxG-EsxH antagonizes
recruitment of HRS, ESCRT-III, and GAL3 to the phagosome. EsxG-EsxH alters HRS localization during
infection, which might impair ESCRT-III recruitment in the context of receptor trafﬁcking, but is unlikely
to account for ESCRT-III inhibition in response to endomembrane damage. (B) During infection with a
ΔesxA mutant, there is reduced phagosome damage. Without phagosomal perforation, M. tuberculosis is
impaired in its ability to manipulate cellular trafﬁcking and immune responses, and therefore, the bacilli
are cleared. (C) Infection with ΔesxHmutants results in enhanced recruitment of HRS, ESCRT-III, and GAL3
to bacilli, which interferes with the bacterial virulence program.
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adaptor in the context of the endomembrane damage response (Fig. 7). We think
EsxG-EsxH is likely to have another activity that allows it to inhibit ESCRT-III recruitment
in response to endomembrane damage during infection. Since EsxG-EsxH relocalizes in
response to membrane damage, another possibility is that EsxG-EsxH competes with
ESCRT recognition or binding to sites of damage. However, since both theM. smegmatis
and M. tuberculosis EsxG-EsxH proteins respond to damaged membranes, but only the
M. tuberculosis proteins promote virulence and impair lysosomal trafﬁcking (35, 41, 42),
M. tuberculosis EsxG-EsxH must have additional activity. So far, the only M. tuberculosis-
speciﬁc function identiﬁed for EsxG-EsxH is its ability to interact with HRS (35), but our
ﬁndings here suggest an additional role or roles. Further work is required to elucidate
exactly how EsxG-EsxH impairs ESCRT and promotes disease. Given the critical impor-
tance of this effector in virulence and immune responses (42, 69, 70), understanding
how it perturbs host cellular function is central to understanding M. tuberculosis
pathogenesis.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The following M. tuberculosis strains were used in this
study: H37Rv (WT), the ΔesxAmutant (32), the ΔesxGmutant (mc27789), the ΔesxG complement (mc27789
with pYUB1335), the ΔesxH mutant (mc27846), the Δpe4-ppe5 (Δppe) mutant (mc27848), the ΔesxH
complement (mc27846 containing pJP130), mc26206 (ΔleuCD ΔpanCD), and mc26230 (ΔRD1 ΔpanCD).
The ΔesxA mutant, mc26206, and mc26230 were provided by William Jacobs, Jr. (Albert Einstein College
of Medicine), and have also been previously characterized by our laboratory (32, 52, 53, 71). The ΔesxG,
ΔesxH, and Δpe4-ppe5 (Δppe) mutants and complementing plasmids were previously described in detail
(41, 42). Previously, we showed that mc26230 exhibits reduced LC3 trafﬁcking compared to mc26206,
consistent with the reduction in xenophagy described for ESX-1mutants (71). Strains were grown at 37°C
in 7H9 medium (Middlebrook 7H9 broth; Difco) supplemented with 0.05% Tween 80 (Sigma), BBL
Middlebrook OADC (oleic acid-albumin-dextrose-catalase) enrichment, and 0.2% glycerol (Sigma). DsRed,
pYUB1335, and pJP130 plasmids were selected with 25 l/ml kanamycin. mCherry-expressing plasmids
were selected with 50 l/ml hygromycin. Medium was supplemented with D-pantothenic acid (24 g/ml)
for strains lacking panCD and L-leucine (50 g/ml) for strains lacking leuCD.
Tissue culture conditions.Murine hematopoietic stem cells were isolated from the tibias and femurs
of 6- to 15-week-old C57BL/6 mice. For differentiation into BMDMs, DMEM (Dulbecco’s modiﬁed Eagle’s
medium [Gibco]) was supplemented with 10% fetal bovine serum (FBS) and 20% L929-conditioned
medium for 7 days. The concentration of L929-conditioned medium was reduced to 10% before
infections. HeLa cells obtained from Michael S. Diamond (Washington University School of Medicine)
were grown in a mixture of DMEM, 2 mM L-glutamine, and 10% heat-inactivated fetal bovine serum
(hiFBS [Invitrogen]). Penicillin/streptomycin (Gibco) was added for passaging of cells and excluded during
infection of BMDMs. U2OS human osteosarcoma cells and RAW264.7 mouse macrophages originally from
the American Type Culture Collection (ATCC [Manassas, VA]) were grown in DMEM supplemented with
10% FBS. Plasmids were transfected into HeLa cells with Effectene (Qiagen). Cells were grown at 37°C in
a 5% CO2 atmosphere.
Plasmid construction. For EsxG-EsxH expression in mammalian cells, M. tuberculosis EsxG and EsxH
were ampliﬁed by PCR using oligonucleotides that added 5= HindIII and 3= BamHI sites (for EsxG) and 5=
BamHI and 3= V5 tag-XbaI (for EsxH). Both EsxG and EsxH-V5 were cloned into pcDNA3.1(). A
self-cleaving viral 2A peptide sequence (EGRGSLLTCGDVEENPGP) with ﬂanking BamHI overhangs was
generated by annealing of complementary oligonucleotides and cloned into the BamHI restriction site
between EsxG and EsxH to generate EsxG-T2A-EsxH-V5 (pET018) and conﬁrmed by sequencing. To
generate the M. smegmatis EsxG-T2A-EsxH-V5 plasmid (pEM01), Genewiz synthesized DNA that was
identical to the insert of pET018, except that the M. tuberculosis EsxG and EsxH sequences were replaced
with M. smegmatis EsxG and EsxH, and then the insert was cloned into the HindIII and XbaI restriction
sites of pET018.
RNAi-mediated silencing. siRNAs for TSG101 (SMARTpool-ON-TARGETplus, L-049922-01) and HRS
(ON-TARGETplus, J-055516-09) were transfected using Hiperfect (Qiagen). RNAi-mediating silencing
of TSG101 and HRS has been reported previously (35). Silencing was performed with 50 nM siRNA
for 2 days before LLOME treatment. ON-TARGETplus nontargeting siRNA 1 (D-001210-01) was used
as a control.
Microscopic analysis of infected cells. For immunoﬂuorescence (IF) microscopy, BMDMs (1 105)
were seeded on 12-mm coverslips in 24-well plates 1 day prior to infection. Macrophages were infected
with DsRed-expressing, mCherry-expressing, or PKH-labeled M. tuberculosis at an MOI of 5. After 3 h,
macrophages were washed with phosphate-buffered saline (PBS) and ﬁxed with 1% paraformaldehyde–
PBS overnight followed by permeabilization in 0.1% vol/vol Triton X-100 (Sigma-Aldrich) in PBS for
10 min at room temperature and blocked for 45 min in 2% bovine serum albumin (BSA) in PBS prior to
immunostaining with the primary and secondary antibodies listed below. Samples were stained with
DAPI (4=,6-diamidino-2-phenylindole) and mounted in Prolong Diamond antifade (Molecular Probes, Life
Technologies). Images were captured using a Nikon Eclipse Ti confocal microscope (Nikon Instruments,
Inc.) equipped with a 60 apochromat oil objective lens. Image acquisition and analysis were done using
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NIS-Elements version 4.40. Brieﬂy, a region of interest (ROI) was drawn in close apposition around each
bacterium or cell (depending upon the experiment), and the ﬂuorescence intensity was measured using
the ROI tool. The numbers of punctae were measured with a spot detector.
In the case of HRS and EEA1 IF in BMDMs, cells were seeded in 8-well chamber slides at 1 105 per
well. The next day, they were infected and ﬁxed as described above. Cells were immunostained with HRS
(72) and EEA1 (rabbit antibody ab2900; Abcam) in 0.1% saponin–2% BSA in PBS. In those experiments,
M. tuberculosis was visualized based upon its autoﬂuorescence using the DAPI ﬁlter. The images were
acquired using Nikon Eclipse TiE/B automated ﬂuorescence microscope with 60; Plan-apochromat, NA
1.4 oil immersion objective, Photometric Cool SNAP HQ2 monochrome digital camera and appropriate
ﬁlter sets for DAPI and TexasRed channel. The 60 z-stack images were acquired, deconvoluted, and
analyzed using Nikon Imaging Software-Elements Advanced Research (NIS-Elements AR, v3.2). The
cellular distribution of HRS and EEA1 was quantiﬁed by thresholding images to select punctae. The
number of punctae was divided by the cell number for each ﬁeld to arrive at the number of punctae per
cell. At least three ﬁelds per sample with an average number of 20 cells per ﬁeld were acquired for image
analysis. The data were normalized to uninfected samples.
Endolysosomal membrane damage. For continuous LLOME treatments, cells seeded on 12-mm
coverslips were exposed to 1 mM LLOME in complete growth medium for 10 to 15 min, unless otherwise
indicated, and then ﬁxed in 4% paraformaldehyde in PBS for 20 min at room temperature and immu-
nostained as described above. For pulse-chase experiments, coverslips were immersed in medium
containing LLOME for 1 min, rinsed in drug-free medium, and then incubated in excess drug-free
medium before processing for immunoﬂuorescence. Where indicated, cells were transfected for 30 to
40 h before LLOME treatment with 400 ng of pET018, pEM01 (described above), or empty vector
(pJP115/pcDNA/GW40/lacZ [Invitrogen]). For experiments assessing the effect of calcium on cellular
responses to endolysosomal damage, cells were incubated in medium containing 25 M BAPTA-AM for
1 h and then switched to medium containing 25 M BAPTA-AM together with LLOME for an additional
15 min. Images were acquired and analyzed as described above.
Silica crystal nanoparticle uptake. Silica nanoparticles (no. tlrl-sio; InvivoGen) were suspended in
ultrapure water according to the manufacturer’s instructions and diluted in complete growth medium to
100 g/ml. The resulting suspension was added to subconﬂuent cells on glass coverslips, and cells were
incubated for 15 min before being ﬁxed and prepared for immunoﬂuorescence.
Time-lapse recording for SRB assay. HeLa cells were seeded in a four-chamber, no. 1.5 glass-
bottom dish (Cellvis) and cultured overnight before being transfected for 36 h with pET018. Transfected
cells were next incubated for 6 h in complete growth medium supplemented with the red ﬂuorescent
dye sulforhodamine B (SRB [S1307]; Molecular Probes) at 200 ng/l and then extensively washed and
chased for 6 h in growth medium lacking SRB to allow the dye to accumulate in late endosomes and
lysosomes. Before imaging, each dish was inscribed with three ﬁduciary marks to facilitate alignment on
the microscope stage (described below). Medium was then replaced with warmed imaging buffer
(20 mM HEPES [pH 7.4] at room temperature, 140 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
10 mM D-glucose, and 5% vol/vol FBS), and the dish was equilibrated for at least 20 min in an INU series
stage-top incubator (Tokai Hit) at 37°C. Additional imaging buffer, intended for preparing drug solutions,
was simultaneously warmed in a separate vessel placed within the stage-top incubator together with the
cells. A grid of individual ﬁelds, covering a total area of approximately 1 mm2, was imaged at 5-min
intervals for a total of 30 min. After the initial time point, acquisition was brieﬂy paused and buffer was
replaced with fresh imaging solution containing 1 mM LLOME. Recordings were acquired on a spinning
disk confocal platform consisting of a Ti-E inverted microscope (Nikon Instruments) and a CSU-X1
variable speed scanner (Yokogawa), using a Nikon 60 1.40 NA CFI Plan apochromat lambda oil
immersion objective, a 561-nm laser, a red emission single-band bandpass ﬁlter (605 35 nm), and a
Zyla 4.2-megapixel sCMOS camera (Andor), using a 16-bit dual ampliﬁer without binning. Axial drift was
compensated using the Nikon Perfect Focus System (PFS). At the end of each recording, cells were ﬁxed
for 15 min at room temperature in 4% wt/vol paraformaldehyde in PBS and immunostained as described
above. Dishes were next aligned on the microscope stage using the inscribed ﬁduciary marks, and the
immunostained cells were imaged by optical sectioning on the same spinning disk confocal platform
described above, using 488-nm and 640-nm lasers and green emission (525 18 nm) and far-red
emission (700 37.5 nm) single-band bandpass ﬁlters. Maximum-intensity projections of each immuno-
stain were then manually aligned to the time-lapse recordings of SRB ﬂuorescence in Nikon NIS-Elements
software. Image analysis was performed as described above.
Antibodies and other materials. LLOME (no. L7393; Sigma-Aldrich) and BAPTA-AM (no. 15551;
Cayman Chemical) were prepared in dimethyl sulfoxide (DMSO) and stored at 80°C in single-use
aliquots. The PKH26 red ﬂuorescent cell linker midi kit (no. MIDI26-1KT), D-pantothenic acid (no. 21210),
and radioimmunprecipitation assay (RIPA) buffer were purchased from Sigma-Aldrich. Silica nanopar-
ticles (no. tlrl-sio) and SRB (no. S1307) were purchased from InvivoGen and Molecular Probes, respec-
tively. siRNAs for TSG101 (SMARTpool-ON-TARGETplus, L-049922-01), HRS (ON-TARGETplus, J-055516-09),
and ON-TARGETplus nontargeting siRNA 1 (D-001210-01) were obtained from Dharmacon. L-Leucine (no.
194694) was purchased from MP Biomedicals.
The following antibodies were used: ALIX, rabbit, 12422-1-AP (ProteinTech); CHMP1A, mouse, sc-
271617 (Santa Cruz); CHMP1B, rabbit, 14639-1-AP (ProteinTech), and mouse, sc-514013 (Santa Cruz);
CHMP4A, rabbit (73); CHMP4B, rabbit, clone 485 (A. Shiels, Washington University School of Medicine);
IST1, rabbit, 19842-1-AP (ProteinTech); EEA1, rabbit, 2411 (Cell Signaling Technology) (for Fig. 7A and B),
and rabbit, ab2900 (Abcam) (for Fig. 6AB and Fig. S6A and B); LAMP1, rabbit, NB120-19294 (Novus); HRS,
mouse (Andrew Bean, The University of Texas Health Science Center at Houston Medical School,
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Houston), and mouse, ALX-804-382 (Enzo Life Sciences); -actin, mouse, BA3R, MA5-15739 (Invitrogen);
V5-tag, mouse, 377500 (Life Technologies); GAL3, rabbit, sc-20157 (Santa Cruz); polyubiquitin, mouse,
clone FK2, 04-263 (Millipore Sigma); anti-EsxG-EsxH, clone 2D1.C3.H5 IgG2b (this study); goat anti-mouse
IgG-horseradish peroxidase (HRP), 31430, (Pierce); goat anti-rabbit IgG-HRP, 32260 (Invitrogen); Alexa
Fluor 488-conjugated goat anti-mouse IgG, A11029 (Invitrogen); Alexa Fluor 594-conjugated goat
anti-mouse IgG, A11032 (Invitrogen); Alexa Fluor 488-conjugated goat anti-rabbit IgG, A11034 (Invitro-
gen); Alexa Fluor 594-conjugated goat anti-rabbit IgG, A11037 (Invitrogen); and Alexa Fluor 647-
conjugated goat anti-rabbit IgG, A21245 (Invitrogen).
To generate monoclonal antibodies against M. tuberculosis EsxG-EsxH, 250 g of recombinant
His-tagged EsxG-EsxH was produced in Escherichia coli as previously described (35) and injected into
mice using TiterMax Gold adjuvant, followed by boosts with incomplete Freund’s adjuvant containing
125 g puriﬁed EsxG-EsxH. Fusion experiments were performed according to standard procedures.
Supernatants from hybridoma clones were screened by indirect enzyme-linked immunosorbent assay
(ELISA) and IF microscopy. Single clones were isolated by repeated limiting dilution cloning. Established
hybridomas were cultivated, and MAbs were puriﬁed from the conditioned medium by using NAb
protein A/G spin columns (ThermoFisher, catalog no. 89958) per the manufacturer’s instructions for
gravity-ﬂow puriﬁcation.
Electron microscopy. BMDMs (1 106/well) were seeded in a 6-well plate 1 day before infection.
Macrophages were infected with H37Rv (WT) or the ΔesxH mutant at an MOI of 10. After 3 h,
macrophages were washed and ﬁxed in 1% paraformaldehyde–0.04% glutaraldehyde (Polysciences, Inc.,
Warrington, PA) in 100 mM PIPES [piperazine-N,N=-bis(2-ethanesulfonic acid)] buffer overnight, followed
by embedding in 10% gelatin overnight with 2.3 M sucrose–20% polyvinylpyrrolidone in PIPES at 4°C.
Samples were frozen in liquid nitrogen and sectioned with a cryo-ultramicrotome. Sections were probed
with primary HRS antibody (from A. Bean) followed by colloidal conjugated secondary antibody (Jackson
ImmunoResearch Laboratories), stained with uranyl acetate/methylcellulose, and analyzed by transmis-
sion electron microscopy.
Protein extracts and Western blotting. BMDMs (1 106/well) were seeded in a 6-well plate 1 day
before infection. BMDMs were infected with H37Rv or the ΔesxH mutant for 1, 2, and 4 hpi at different
MOI (10, 25, and 50). Cells were removed from culture dishes, washed in PBS, and lysed in RIPA buffer
(150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris [pH 8.0]) and
subjected to Western blotting. Blots were probed with indicated antibodies. HeLa cells transfected with
indicated constructs were cultured for 40 h and subsequently treated with or without 1 mM LLOME for
15 min. After LLOME treatment, cells were washed with PBS and lysed in RIPA buffer and then subjected
to Western blotting. The blots were probed with the indicated antibodies.
Mice. The Washington University School of Medicine Institutional Animal Care and Use Committee
approved all work with mice. Euthanasia was performed prior to bone marrow harvest in accordance
with the 2013 AVMA Guidelines for the Euthanasia of Animals (https://www.avma.org/KB/Policies/
Documents/euthanasia.pdf).
Image analysis and reproduction. For all microscopy experiments, contrast was not altered before
image analysis. In cases where the contrast was enhanced for reproduced images, the adjustment was
the same for all samples.
Statistical analysis. The data shown are representative of 2 or more independent experiments. In all
ﬁgures, error bars indicate the mean  standard error of the mean (SEM). The unpaired, two-tailed
Student’s t test, one-way analysis of variance (ANOVA) with Tukey’s multiple-comparison test, or Fisher’s
exact test was used to assess the statistical signiﬁcance of the comparison of experimental groups using
GraphPad Prism software.
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